| Epidemiology, pathophysiology, and management of hepatorenal syndrome AA Amin, EI Alabsawy, R Jalan, A Davenport Seminars in Nephrology 39 (1), 17-30, 2019 | 114 | 2019 |
| Cholemic nephropathy reloaded P Fickert, AR Rosenkranz Seminars in Liver Disease 40 (01), 091-100, 2020 | 37 | 2020 |
| Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure AJC Kerbert, S Gupta, E Alabsawy, I Dobler, I Lønsmann, A Hall, ... JHEP Reports 3 (6), 100355, 2021 | 20 | 2021 |
| Long‐term outcome in patients with acute liver failure A Putignano, F Figorilli, E Alabsawy, B Agarwal, R Jalan Liver International 38 (12), 2228-2238, 2018 | 18 | 2018 |
| Overt hepatic encephalopathy is an independent risk factor for de novo infection in cirrhotic patients with acute decompensation E Alabsawy, Shalimar, MF Sheikh, MP Ballester, SK Acharya, B Agarwal, ... Alimentary Pharmacology & Therapeutics 55 (6), 722-732, 2022 | 10 | 2022 |
| A novel smartphone scleral‐image based tool for assessing jaundice in decompensated cirrhosis patients K Kazankov, M Nixon‐Hill, R Kumar, A Amin, E Alabsawy, A Chikhlia, ... Journal of Gastroenterology and Hepatology 38 (2), 330-336, 2023 | 3 | 2023 |
| Hepatopulmonary syndrome as the first and only manifestation of cirrhosis in a patient with hypopituitarism E Alabsawy, Y Serry, S Kotha, P Berry, G Tritto BMJ Case Reports CP 14 (9), e244805, 2021 | 3 | 2021 |
| Potential novel approaches to prevent the risk of infection in patients with variceal bleeding E Alabsawy, R Jalan Journal of Hepatology 76 (3), 751-752, 2022 | 1 | 2022 |
| A multi-centre, randomized controlled study, to evaluate the safety and performance of the DIALIVE liver dialysis device in patients with acute on chronic liver failure (ACLF … B Agarwal, F Saliba, DR Tomescu, CR Banares, D Martin, V Stadlbauer, ... | 1 | 2021 |
| de novo infection in hepatic encephalopathy—The culprit or the victim? Authors' reply E Alabsawy, Shalimar, R Jalan Alimentary Pharmacology & Therapeutics 55 (9), 1231-1232, 2022 | | 2022 |
| Editorial: infections and hepatic encephalopathy—does the chicken or the egg come first? A novel perspective at the horizon. Authors’ reply RJ Eman Alabsawy, Shalimar Alimentary pharmacology & therapeutics 55 (6), 746-747, 2022 | | 2022 |
| Pathophysiological basis of resolution of Acute-on-Chronic Liver Failure (ACLF) induced by the novel liver dialysis device, DIALIVE RB Canizares, F Saliba, B Agarwal, DR Tomescu, D Martin, V Stadlbauer, ... | | 2021 |
| P: 35 Hepatic Encephalopathy Is an Independent Risk Factor for the Occurrence of Infection in Cirrhotic Patients With Acute Decompensation E Alabsawy, B Agarwal, R Jalan Official journal of the American College of Gastroenterology| ACG 114, S17-S18, 2019 | | 2019 |
| Long‐term outcome in patients with acute liver failure. F Figorilli, E Alabsawy, R Jalan, A Putignano, B Agarwal Liver International 38 (12), 2018 | | 2018 |
Ahmed Adel AminLecturer of Gastroenterology and Hepatology, Assiut University Hospital, Egypt在 aun.edu.eg 的电子邮件经过验证
